Latest article
Dasiglucagon promising for extreme hypoglycemia in youngsters with sort 1 diabetes
medwireNews: Dasiglucagon, a next-generation glucagon analog in a ready-to-use formulation, rapidly restores...
Novo Nordisk to launch GLP-1 injectible diabetes drug in pill type by February
Novo Nordisk, headquartered in Denmark and a leader in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022....
Is Coronavirus Triggering Diabetes In Covid Sufferers?
Now, with Covid 19 for over a year and a half, our understanding of the effects and complications it can cause on the human...